Cargando…

Editorial: Secondary Dyslipidemias

Detalles Bibliográficos
Autores principales:	Elisaf, Moses, Tsimihodimos, Vasilis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109669/ https://www.ncbi.nlm.nih.gov/pubmed/21660197 http://dx.doi.org/10.2174/1874192401105010022

Ejemplares similares

Dyslipidemia Associated with Chronic Kidney Disease
por: Tsimihodimos, Vasilis, et al.
Publicado: (2011)

Hypercalcemia and acute renal failure associated with calcium carbonate consumption in a patient with hypoparathyroidism
por: Mitrogianni, Zoi, et al.
Publicado: (2014)

No effect of fenugreek, bergamot and olive leaf extract on glucose homeostasis in patients with prediabetes: a randomized double-blind placebo-controlled study
por: Florentin, Matilda, et al.
Publicado: (2019)

PCSK9 and carbohydrate metabolism: A double-edged sword
por: Filippatos, Theodosios D, et al.
Publicado: (2017)

Early Signs of Atherogenic Features in the HDL Lipidomes of Normolipidemic Patients Newly Diagnosed with Type 2 Diabetes
por: Kostara, Christina E., et al.
Publicado: (2020)

Nicotinic acid/laropiprant reduces platelet count but increases mean platelet volume in patients with primary dyslipidemia
por: Kei, Anastazia, et al.
Publicado: (2014)

Effect of Plant Polyphenols on Adipokine Secretion from Human SGBS Adipocytes
por: Derdemezis, Christos S., et al.
Publicado: (2011)

LDL cholesterol estimation in patients with the metabolic syndrome
por: Gazi, Irene, et al.
Publicado: (2006)

Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
por: Filippatos, Theodosios D., et al.
Publicado: (2017)

Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid
por: Moutzouri, Elisavet, et al.
Publicado: (2010)

The Impact of Dietary Glycemic Index and Glycemic Load on Postprandial Lipid Kinetics, Dyslipidemia and Cardiovascular Risk
por: Lambadiari, Vaia, et al.
Publicado: (2020)

Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?
por: Tanaka, Ana Cristina Sayuri
Publicado: (2018)

Management of Dyslipidemia in Secondary Prevention of Cardiovascular Disease: The Gap between Theory and Practice
por: Santangelo, Gloria, et al.
Publicado: (2022)

Editorial
por: Vasiliou, Vasilis
Publicado: (2011)

Editorial
por: Vasiliou, Vasilis
Publicado: (2011)

Editorial
por: Vasiliou, Vasilis
Publicado: (2009)

Editorial
por: Vasiliou, Vasilis
Publicado: (2009)

Editorial
por: Vasiliou, Vasilis
Publicado: (2009)

Editorial
por: Vasiliou, Vasilis
Publicado: (2008)

Editorial: Rare dyslipidemias
por: Sadiq, Fouzia, et al.
Publicado: (2023)

Dyslipidemia and Breast Cancer
por: Aggarwal, Neelam, et al.
Publicado: (2018)

Endothelial stiffening in dyslipidemia
por: Le Master, Elizabeth, et al.
Publicado: (2019)

Attainment of cholesterol target values in Greece: results from the Dyslipidemia International Study II
por: Liberopoulos, Evangelos, et al.
Publicado: (2018)

The Draupadi of dyslipidemia: Familial hypercholesterolemia
por: Kalra, Sanjay, et al.
Publicado: (2016)

The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology
por: Dimou, Aikaterini, et al.
Publicado: (2022)

Frequency of secondary dyslipidemia in obese children
por: Korsten-Reck, Ulrike, et al.
Publicado: (2008)

Effect of Clinical and Laboratory Parameters on HDL Particle Composition
por: Kostara, Christina E., et al.
Publicado: (2023)

Role of Complementary and Alternative Medicine in Controlling Dyslipidemia
por: Qidwai, Waris, et al.
Publicado: (2014)

Time to consider an Asian guideline for management of dyslipidemia?
por: Yokote, Koutaro, et al.
Publicado: (2012)

Diets, Foods and Food Components’ Effect on Dyslipidemia
por: Fogacci, Federica, et al.
Publicado: (2021)

Novel Molecules in Diabetes Mellitus, Dyslipidemia and Cardiovascular Disease
por: Vesa, Cosmin Mihai, et al.
Publicado: (2023)

Editorial for the Special Issue “Microbial Nonribosomal Synthesis of Secondary Metabolites”
por: Cociancich, Stéphane, et al.
Publicado: (2022)

An Update on the Role of Arterial Stiffness in Heart Failure and the Treatment of Dyslipidemia
por: Feola, Mauro
Publicado: (2023)

Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?
por: Radaelli, Graciane, et al.
Publicado: (2018)

Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
por: Lin, Hung-Yao, et al.
Publicado: (2022)

Editorial: Cardiovascular diseases in autoimmune diseases: Dyslipidemia and vascular inflammation
por: Solow, E. Blair, et al.
Publicado: (2022)

Editorial: Dyslipidemia, obesity and coronavirus disease 2019 (COVID-19)
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2022)

Body mass index impacts the choice of lipid‐lowering treatment with no correlation to blood cholesterol – Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS)
por: Ferrières, Jean, et al.
Publicado: (2018)

Native valve endocarditis due to Micrococcus luteus: a case report and review of the literature
por: Miltiadous, George, et al.
Publicado: (2011)

New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China()
por: Hu, Da-Yi
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n61c7qfr9e42usajrnp4bd7vn7